Talkspace (TALK) | Financial Analysis & Statements
Talkspace Inc. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
63.0M
Gross Profit
26.9M
42.74%
Operating Income
3.8M
6.08%
Net Income
4.8M
7.56%
EPS (Diluted)
$0.03
Balance Sheet Metrics
Total Assets
134.9M
Total Liabilities
17.8M
Shareholders Equity
117.0M
Debt to Equity
0.15
Cash Flow Metrics
Operating Cash Flow
5.7M
Free Cash Flow
2.1M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Talkspace Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 228.9M | 187.6M | 150.0M | 119.6M | 113.7M |
| Cost of Goods Sold | 130.5M | 101.8M | 75.7M | 59.2M | 46.9M |
| Gross Profit | 98.3M | 85.8M | 74.4M | 60.3M | 66.8M |
| Gross Margin % | 43.0% | 45.8% | 49.6% | 50.5% | 58.7% |
| Operating Expenses | |||||
| Research & Development | 9.5M | 10.5M | 17.6M | 21.7M | 15.9M |
| Selling, General & Administrative | 75.6M | 73.3M | 73.9M | 109.1M | 135.4M |
| Other Operating Expenses | 7.2M | 6.5M | 6.2M | 6.6M | 9.4M |
| Total Operating Expenses | 92.3M | 90.3M | 97.6M | 137.4M | 160.7M |
| Operating Income | 3.2M | -4.5M | -23.2M | -77.0M | -93.9M |
| Operating Margin % | 1.4% | -2.4% | -15.5% | -64.4% | -82.6% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | - | - | - | - | - |
| Other Non-Operating Income | - | - | - | -6.1M | - |
| Pre-tax Income | 8.4M | 1.2M | -19.0M | -79.4M | -62.7M |
| Income Tax | 574.0K | 94.0K | 218.0K | 254.0K | 47.0K |
| Effective Tax Rate % | 6.9% | 7.6% | 0.0% | 0.0% | 0.0% |
| Net Income | 7.8M | 1.1M | -19.2M | -79.7M | -62.7M |
| Net Margin % | 3.4% | 0.6% | -12.8% | -66.6% | -55.2% |
| Key Metrics | |||||
| EBITDA | 6.0M | -3.6M | -22.0M | -69.5M | -92.0M |
| EPS (Basic) | - | $0.01 | $-0.12 | $-0.51 | $-0.72 |
| EPS (Diluted) | - | $0.01 | $-0.12 | $-0.51 | $-0.72 |
| Basic Shares Outstanding | - | 168906900 | 165039920 | 156885256 | 86776000 |
| Diluted Shares Outstanding | - | 168906900 | 165039920 | 156885256 | 86776000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Talkspace Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 37.4M | 76.7M | 123.9M | 138.5M | 198.3M |
| Short-term Investments | 55.2M | 41.1M | - | - | - |
| Accounts Receivable | 16.1M | 9.6M | 10.2M | 9.6M | 5.5M |
| Inventory | - | - | - | - | - |
| Other Current Assets | 2.4M | 2.7M | 5.7M | 4.4M | 9.6M |
| Total Current Assets | 111.1M | 130.2M | 139.8M | 152.6M | 213.3M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 144.0K | 139.0K | - | - | - |
| Goodwill | 6.6M | 1.3M | 1.8M | 2.5M | 15.7M |
| Intangible Assets | - | 1.3M | 1.8M | 2.5M | 3.4M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 4.7M | 897.0K | 321.0K | 491.0K | 82.0K |
| Total Non-Current Assets | 23.8M | 8.5M | 2.4M | 3.7M | 10.3M |
| Total Assets | 134.9M | 138.7M | 142.2M | 156.3M | 223.6M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 8.5M | 7.7M | 6.1M | 6.5M | 7.4M |
| Short-term Debt | - | - | - | - | - |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 1.6M | 1.2M | 3.0M | 2.9M | 2.6M |
| Total Current Liabilities | 17.4M | 19.0M | 21.6M | 27.3M | 27.2M |
| Non-Current Liabilities | |||||
| Long-term Debt | - | - | - | - | - |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 452.0K | 569.0K | 85.0K | 461.0K | 86.0K |
| Total Non-Current Liabilities | 452.0K | 2.3M | 1.9M | 1.4M | 4.2M |
| Total Liabilities | 17.8M | 21.3M | 23.6M | 28.7M | 31.3M |
| Equity | |||||
| Common Stock | 17.0K | 17.0K | 16.0K | 16.0K | 15.0K |
| Retained Earnings | -261.4M | -269.2M | -270.4M | -251.2M | -171.5M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 117.0M | 117.4M | 118.6M | 127.5M | 192.3M |
| Key Metrics | |||||
| Total Debt | 0 | 0 | 0 | 0 | 0 |
| Working Capital | 93.7M | 111.2M | 118.2M | 125.2M | 186.2M |
Balance Sheet Composition
Talkspace Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 7.8M | 1.1M | -19.2M | -79.7M | -62.7M |
| Depreciation & Amortization | 2.9M | 859.0K | 1.2M | 1.4M | 2.0M |
| Stock-Based Compensation | 8.4M | 9.2M | 8.4M | 12.1M | 27.4M |
| Working Capital Changes | -6.4M | 5.3M | -3.5M | -2.7M | -5.1M |
| Operating Cash Flow | 12.5M | 16.3M | -13.3M | -68.8M | -38.3M |
| Investing Activities | |||||
| Capital Expenditures | - | - | -141.0K | -317.0K | -663.0K |
| Acquisitions | -4.9M | - | - | 0 | 0 |
| Investment Purchases | -49.3M | -41.1M | - | - | - |
| Investment Sales | 36.1M | - | - | - | - |
| Investing Cash Flow | -18.2M | -41.3M | -141.0K | -317.0K | -663.0K |
| Financing Activities | |||||
| Share Repurchases | -17.2M | -11.0M | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | - | 0 | 0 | 6.0M |
| Debt Repayment | - | - | 0 | 0 | -6.0M |
| Financing Cash Flow | -19.9M | -14.2M | -810.0K | -1.5M | 249.3M |
| Free Cash Flow | -2.1M | 6.3M | -16.5M | -61.4M | -66.4M |
| Net Change in Cash | -25.6M | -39.2M | -14.2M | -70.7M | 210.3M |
Cash Flow Trend
Talkspace Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
129.63
Forward P/E
23.57
Price to Book
7.39
Price to Sales
3.79
PEG Ratio
0.65
Profitability Ratios
Profit Margin
3.41%
Operating Margin
6.08%
Return on Equity
6.65%
Return on Assets
1.44%
Financial Health
Current Ratio
6.38
Debt to Equity
0.00
Beta
1.14
Per Share Data
EPS (TTM)
$0.04
Book Value per Share
$0.70
Revenue per Share
$1.37
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| TALK | 866.0M | 129.63 | 7.39 | 6.65% | 3.41% | 0.00 |
| Ge Healthcare | 31.9B | 15.92 | 3.18 | 22.38% | 10.10% | 98.72 |
| Veeva Systems | 26.5B | 29.57 | 3.66 | 13.93% | 28.45% | 1.33 |
| Omnicell | 1.7B | 918.75 | 1.34 | 0.17% | 0.17% | 16.59 |
| Teladoc Health | 1.0B | - | 0.74 | -13.93% | -7.92% | 75.06 |
| Certara | 969.0M | 105.00 | 0.95 | -0.15% | -0.38% | 28.96 |
Financial data is updated regularly. All figures are in the company's reporting currency.






